Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
Public ClinicalTrials.gov record NCT03341962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of IMU-838 for induction and maintenance therapy with an option for open-label treatment extension in moderate-to-severe ulcerative colitis (CALDOSE-1).
Study identification
- NCT ID
- NCT03341962
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2018 (Actual)
- Primary completion
- Nov 16, 2022 (Actual)
- Completion
- Nov 16, 2022 (Actual)
- Last update posted
- Mar 5, 2024
2018 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Del Sol Research Management, LLC | Tucson | Arizona | 85710 | — |
| Axis Clinical Trials | Los Angeles | California | 90036 | — |
| Ventura Clinical Trials | Ventura | California | 93003 | — |
| Alliance Medical Research, LLC | Lighthouse PT | Florida | 33071 | — |
| Medley Research Associates | Medley | Florida | 33166 | — |
| Global Life Research LLC | Miami | Florida | 33155-4630 | — |
| Family Clinical Trials | Pembroke Pines | Florida | 33026-3240 | — |
| Clinical Research Trials of Florida, Inc. | Tampa | Florida | 33607 | — |
| Atlanta Gastroenterology Associates, LLC | Atlanta | Georgia | 30308 | — |
| McFarland Clinic, P.C. | Ames | Iowa | 50010 | — |
| Commonwealth Clinical Studies | Brockton | Massachusetts | 02302 | — |
| PMG Research of Salisbury, LLC | Salisbury | North Carolina | 28144 | — |
| Clinical Trials of South Carolina | Charleston | South Carolina | 29406-7132 | — |
| First Street Surgical Hospital | Bellaire | Texas | 77401 | — |
| Digestive Health Specialists | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 116 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03341962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03341962 live on ClinicalTrials.gov.